AngioDynamics ANGO
Valuation
Multiples measured against the stock's own five-year history
Around its usual level · 46th percentile, 5-year average -10.6x
Near the top of its 5-year range · 93rd percentile, 5-year average 1.8x
#3755 of 5311 stocks by PB (1 = cheapest)
Above its usual level · 76th percentile, 5-year average 1.6x
#2391 of 5146 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 3.08 | – | 1.83 | 93% (pricier than usual) | #3755 of 5311 (1 = cheapest) |
| PE | -15.18 | -20.10 | -10.56 | 46% (cheaper than usual) | – |
| PS | 1.86 | 1.77 | 1.61 | 76% (pricier than usual) | #2391 of 5146 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on ANGO.
Sign in to join the discussion.